Journal of Neuroimmune Pharmacology

, Volume 2, Issue 3, pp 243–250

Stem Cell Transplantation: A Promising Therapy for Parkinson’s Disease

Invited Review


Parkinson’s disease is one of the most common neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. Pharmacological therapies are valuable but suffer from two main drawbacks: side effects and loss of efficacy with disease progression. Surgical treatment is no better than drugs. Transplantation of embryonic mesencephalic tissue has emerged as a therapeutic alternative, but the unstable efficiency and the shortage of embryonic donors limit its clinical application. Recent advances in stem cell research inspire our hope that stem cell transplantation to replace degenerated neurons may be a promising therapy for Parkinson’s disease. There are three sources of stem cells currently in testing: embryonic stem cells, neural stem cells, and mesenchymal stem cells. The stem cell transplantation in the animal model of Parkinson’s disease proves that it is capable of relieving symptoms and restoring damaged brain function. Future stem cell research should focus not only on ameliorating the symptoms of Parkinson’s disease but also on neuroprotection or neurorescue that can favorably modify the natural course and slow the progression of the disease.


stem cells Parkinson’s disease dopaminergic neurons transplantation regeneration 

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Institute of Neurology, Ruijin HospitalJiao Tong University School of MedicineShanghaiChina
  2. 2.Institute of Health SciencesShanghai Institutes for Biological Sciences of Chinese Academy of Science and Shanghai Jiao Tong University School of MedicineShanghaiChina

Personalised recommendations